<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To estimate hazard ratio (HR) of first incident fatal/non-fatal <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) in female/male type 2 diabetic patients, with tight versus adverse control of HbA1c and blood pressure (BP) at baseline, age 30-70 years, no baseline <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>, followed for mean 5.7 years </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: 2593 patients with tight control of HbA1c &lt;7.5% and BP &lt; or = 140/90 mmHg (median 6.5%/130/80 mmHg), and 2160 patients with adverse control 7.5-9.0%/141-190/91-110 mmHg (median 8.1%/155/85 mmHg) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The hazard ratio (HR) for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> with tight/adverse control was 0.67 (0.55-0.80; p&lt;0.001), adjusting for age, sex, duration, hypoglycaemic treatment, smoking, BMI, <z:chebi fb="23" ids="18059">lipid</z:chebi>-lowering drugs, <z:chebi fb="0" ids="35674">antihypertensive drugs</z:chebi>, <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Adjusted HR for <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e>, <z:hpo ids='HP_0001297'>stroke</z:hpo> and total mortality were 0.72 (0.56-0.92; p=0.01), 0.69 (0.55-0.86; p&lt;0.001), 0.62 (0.45-0.84; p&lt;0.001), 1.00 (0.72-1.39) </plain></SENT>
<SENT sid="4" pm="."><plain>The partial population-attributable risk percent for <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> was 23%, 33%, 29% if adverse HbA1c/BP control could be avoided, while 43%, 38%, 39% with overweight and smoking also avoided </plain></SENT>
<SENT sid="5" pm="."><plain>Baseline lower BMI and absence of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> were associated with tight control </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Median difference of HbA1c/BP 1.6%/25/5 mmHg between tight and adverse control considerably reduced the risk of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The findings call for a multi-factorial approach to improve HbA1c, BP, <z:hpo ids='HP_0001513'>obesity</z:hpo>, smoking, and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
</text></document>